• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Society for Medical Oncology (ESMO) Congress - Articles and news items


FDA grants priority review for Novartis’ first-line treatment of HR+/HER2- advanced breast cancer

Industry news / 7 November 2016 / Niamh Louise Marriott, Digital Content Producer

The US Food and Drug Administration (FDA) accepted Novartis’ new drug application (NDA) for filing and granted priority review for LEE011 (ribociclib)…


ESMO 2016: New data from Eisai’s oncology portfolio for halaven (eribulin), lenvima (lenvatinib) and kisplyx (lenvatinib)

Industry news / 4 October 2016 / Niamh Louise Marriott, Digital Content Producer

European Pharmaceutical Review will of course keep you up to date with all the latest pharma news from the conference. Here’s a preview snippet…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +